3-(4-Bromobutyl)oxolane → 2-[(2-Cyclopropylethyl)oxy]-8-(methyloxy)-9-[4-(tetrahydro-3-furanyl)butyl]-9H-purin-6-amine
Reaktionsgleichung
FC(F)(F)C(O)=O.[CH:8]1([CH2:11][CH2:12][O:13][C:14]2[NH:15][C:16]([NH2:25])=[C:17]3[C:21]([N:22]=2)=[N:20][C:19]([O:23][CH3:24])=[N:18]3)[CH2:10][CH2:9]1.Br[CH2:27][CH2:28][CH2:29][CH2:30][CH:31]1[CH2:35][CH2:34][O:33][CH2:32]1>>[CH:8]1([CH2:11][CH2:12][O:13][C:14]2[N:22]=[C:21]3[C:17]([N:18]=[C:19]([O:23][CH3:24])[N:20]3[CH2:27][CH2:28][CH2:29][CH2:30][CH:31]3[CH2:35][CH2:34][O:33][CH2:32]3)=[C:16]([NH2:25])[N:15]=2)[CH2:10][CH2:9]1Komponenten
3
Versuchsvorschrift
Prepared similarly to Intermediate 216 from 2-[(2-cyclopropylethyl)oxy]-8-(methyloxy)-1H-purin-6-amine trifluoroacetate and 3-(4-bromobutyl)tetrahydrofuran.
Quellen und Nachweise
- ORD-Eintrag
- ord-bd1c9fe00bc54f5495b4e8cddaa3affd
- Quelldatensatz
- uspto-grants-2011_07